mci 9038 has been researched along with Activated Protein C Resistance in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadauke, S; Khor, B; Van Cott, EM | 1 |
| Shaikh, S; Van Cott, EM | 1 |
| Dorion, RP; Gilbert, C; Klayman, M; Murdock, JD; Stammers, AH; Trowbridge, C; Woods, E; Yen, B | 1 |
1 trial(s) available for mci 9038 and Activated Protein C Resistance
| Article | Year |
|---|---|
The effect of argatroban on activated protein C resistance.
Topics: Activated Protein C Resistance; Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Blood Coagulation; Female; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides | 2009 |
2 other study(ies) available for mci 9038 and Activated Protein C Resistance
| Article | Year |
|---|---|
Activated protein C resistance testing for factor V Leiden.
Topics: Activated Protein C Resistance; Adult; Antithrombins; Arginine; Benzimidazoles; beta-Alanine; Biological Assay; Blood Coagulation Tests; Child; Dabigatran; Factor V; Factor Xa; False Positive Reactions; Female; Hirudins; Humans; Lupus Coagulation Inhibitor; Morpholines; Peptide Fragments; Pipecolic Acids; Pregnancy; Protein C; Recombinant Proteins; Rivaroxaban; Sulfonamides; Thiophenes; Warfarin | 2014 |
Coagulation management of a patient with factor V Leiden mutation, lupus anticoagulant, and activated protein C resistance: a case report.
Topics: Activated Protein C Resistance; Adult; Anticoagulants; Arginine; Coronary Stenosis; Factor V; Female; Heparin, Low-Molecular-Weight; Humans; Intraoperative Care; Lupus Coagulation Inhibitor; Pipecolic Acids; Postoperative Care; Sulfonamides; Thrombocytopenia | 2005 |